Answers are grounded in this paper and cite their sources.
BACKGROUND & AIMS: Intrahepatic cholangiocarcinoma remains a lethal malignancy with a lack of effective therapies, underscoring the critical need to identify novel therapeutic targets. The high-mobility group protein A2 is an oncogenic architectural transcription factor aberrantly overexpressed in multiple cancers; yet its function and regulatory mechanisms in intrahepatic cholangiocarcinoma are poorly defined. This study aimed to elucidate the clinical significance and molecular mechanism of high-mobility group protein A2 in intrahepatic cholangiocarcinoma progression. METHODS: We integrated analyses across 4 independent intrahepatic cholangiocarcinoma cohorts (The Cancer Genome Atlas, 2 Zhongshan Hospital cohorts, and our 192-patient institutional cohort). Functional investigations were conducted using intrahepatic cholangiocarcinoma cell lines and multiple mouse models, including xenograft, syngeneic, YAP/AKT-driven spontaneous intrahepatic cholangiocarcinoma, and metastasis models. RESULTS: We demonstrated that high-mobility group protein A2 was significantly upregulated in intrahepatic cholangiocarcinoma, correlating with poor survival, and exhibited sexually dimorphic prognostic effects with a female-specific link to perineural invasion. Functionally, high-mobility group protein A2 depletion suppressed intrahepatic cholangiocarcinoma cell proliferation, migration, in vivo tumor growth and metastasis. Mechanistically, high-mobility group protein A2 expression was positively regulated by the N6-methyladenosine reader insulin-like growth factor 2 messenger RNA-binding protein 1, which directly bound to and stabilized high-mobility group protein A2 messenger RNA via its KH3-4 domains in an N6-methyladenosine-dependent manner. High insulin-like growth factor 2 messenger RNA-binding protein 1 expression predicted poor intrahepatic cholangiocarcinoma prognosis, was required for high-mobility group protein A2-driven progression, and the axis promoted PI3K-AKT pathway activation. CONCLUSIONS: Our results reveal a critical role for the insulin-like growth factor 2 messenger RNA-binding protein 1-high-mobility group protein A2 axis in intrahepatic cholangiocarcinoma pathogenesis, thereby highlighting its potential as a therapeutic target.
No takes yet. Share an insight, caveat, or question.
Guo et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: